Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marion Hitchcock
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells Towards Taxanes, ATR and PARP Inhibitors in Vitro and in Vivo
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Brca2Deficiency Sensitizes Cells to PARP Inhibition
Cancer Research
Cancer Research
Oncology
Resistance to PARP Inhibitors by SLFN11 Inactivation Can Be Overcome by ATR Inhibition
Oncotarget
Oncology
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
In Vitro and in Vivo Tumor Growth Inhibition by Glutathione Disulfide Liposomes
Cancer Growth and Metastasis
Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells
Radiation Research
Nuclear Medicine
Radiology
Radiation
Imaging
Biophysics
Autophagy Inhibition Sensitizes LY3023414-induced Anti-Glioma Cell Activity in Vitro and in Vivo
Oncotarget
Oncology
PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Cancer Research
Cancer Research
Oncology
Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes